

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cardiac myofibril assembly (GO:0055003) | 9.67750963 |
| 2 | sarcomere organization (GO:0045214) | 9.59665654 |
| 3 | myofibril assembly (GO:0030239) | 8.44404019 |
| 4 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 8.22538784 |
| 5 | * muscle filament sliding (GO:0030049) | 8.01482853 |
| 6 | * actin-myosin filament sliding (GO:0033275) | 8.01482853 |
| 7 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 7.42264023 |
| 8 | * skeletal muscle contraction (GO:0003009) | 7.31876235 |
| 9 | * cardiac muscle contraction (GO:0060048) | 7.04978792 |
| 10 | cardiac muscle cell development (GO:0055013) | 6.94188685 |
| 11 | * actin-mediated cell contraction (GO:0070252) | 6.66949688 |
| 12 | cardiac cell development (GO:0055006) | 6.53193326 |
| 13 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 6.46389446 |
| 14 | * cardiac muscle tissue morphogenesis (GO:0055008) | 6.37548625 |
| 15 | tricarboxylic acid cycle (GO:0006099) | 6.35037448 |
| 16 | cardiac muscle hypertrophy (GO:0003300) | 6.30925336 |
| 17 | regulation of relaxation of muscle (GO:1901077) | 6.30350560 |
| 18 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.29209120 |
| 19 | actomyosin structure organization (GO:0031032) | 6.27413711 |
| 20 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.20878164 |
| 21 | adult heart development (GO:0007512) | 6.18277562 |
| 22 | heart contraction (GO:0060047) | 6.10346009 |
| 23 | heart process (GO:0003015) | 6.10346009 |
| 24 | regulation of sarcomere organization (GO:0060297) | 6.03463388 |
| 25 | * ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 5.98227361 |
| 26 | striated muscle hypertrophy (GO:0014897) | 5.96357944 |
| 27 | creatine metabolic process (GO:0006600) | 5.93210654 |
| 28 | plasma membrane repair (GO:0001778) | 5.91129109 |
| 29 | response to muscle activity (GO:0014850) | 5.73590159 |
| 30 | ventricular cardiac muscle cell action potential (GO:0086005) | 5.69821922 |
| 31 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 5.68625052 |
| 32 | * muscle tissue morphogenesis (GO:0060415) | 5.67994855 |
| 33 | regulation of skeletal muscle contraction (GO:0014819) | 5.62801210 |
| 34 | * striated muscle contraction (GO:0006941) | 5.56279218 |
| 35 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.54217650 |
| 36 | heart trabecula formation (GO:0060347) | 5.49213755 |
| 37 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 5.41357882 |
| 38 | muscle hypertrophy (GO:0014896) | 5.30238242 |
| 39 | regulation of the force of heart contraction (GO:0002026) | 5.28355330 |
| 40 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.20995837 |
| 41 | regulation of striated muscle contraction (GO:0006942) | 5.19784893 |
| 42 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 5.04105922 |
| 43 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.98370196 |
| 44 | * actin filament-based movement (GO:0030048) | 4.93915908 |
| 45 | regulation of cell communication by electrical coupling (GO:0010649) | 4.86814828 |
| 46 | * regulation of actin filament-based movement (GO:1903115) | 4.86731737 |
| 47 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.85449667 |
| 48 | ATP synthesis coupled proton transport (GO:0015986) | 4.85449667 |
| 49 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.79536687 |
| 50 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.73275153 |
| 51 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.73091780 |
| 52 | skeletal muscle adaptation (GO:0043501) | 4.70318154 |
| 53 | regulation of membrane repolarization (GO:0060306) | 4.66908672 |
| 54 | skeletal muscle fiber development (GO:0048741) | 4.64552038 |
| 55 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 4.62359682 |
| 56 | carnitine shuttle (GO:0006853) | 4.56623420 |
| 57 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.54846111 |
| 58 | regulation of cardioblast differentiation (GO:0051890) | 4.54741990 |
| 59 | cell communication involved in cardiac conduction (GO:0086065) | 4.53768076 |
| 60 | cardiac muscle adaptation (GO:0014887) | 4.46224747 |
| 61 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 4.46224747 |
| 62 | muscle hypertrophy in response to stress (GO:0003299) | 4.46224747 |
| 63 | oxidative phosphorylation (GO:0006119) | 4.41259702 |
| 64 | negative regulation of protein localization to cell surface (GO:2000009) | 4.33649426 |
| 65 | muscle fiber development (GO:0048747) | 4.33194187 |
| 66 | respiratory electron transport chain (GO:0022904) | 4.32022489 |
| 67 | myotube cell development (GO:0014904) | 4.30638397 |
| 68 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.28421660 |
| 69 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.28338332 |
| 70 | ventricular cardiac muscle cell development (GO:0055015) | 4.23379869 |
| 71 | regulation of cofactor metabolic process (GO:0051193) | 4.20302282 |
| 72 | regulation of coenzyme metabolic process (GO:0051196) | 4.20302282 |
| 73 | electron transport chain (GO:0022900) | 4.19751434 |
| 74 | regulation of cardiac muscle contraction (GO:0055117) | 4.14532522 |
| 75 | cell communication by electrical coupling (GO:0010644) | 4.11896259 |
| 76 | regulation of heart rate (GO:0002027) | 4.08807188 |
| 77 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 4.03417453 |
| 78 | skeletal muscle tissue development (GO:0007519) | 4.02639371 |
| 79 | cardiac muscle cell action potential (GO:0086001) | 3.97991089 |
| 80 | negative regulation of potassium ion transport (GO:0043267) | 3.97256108 |
| 81 | striated muscle cell development (GO:0055002) | 3.96630037 |
| 82 | muscle cell fate commitment (GO:0042693) | 3.96089745 |
| 83 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.95049139 |
| 84 | fatty acid transmembrane transport (GO:1902001) | 3.91852767 |
| 85 | glycogen catabolic process (GO:0005980) | 3.91044266 |
| 86 | muscle cell cellular homeostasis (GO:0046716) | 3.88216684 |
| 87 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.85445942 |
| 88 | muscle adaptation (GO:0043500) | 3.85337321 |
| 89 | glucan biosynthetic process (GO:0009250) | 3.84424963 |
| 90 | glycogen biosynthetic process (GO:0005978) | 3.84424963 |
| 91 | relaxation of cardiac muscle (GO:0055119) | 3.80236525 |
| 92 | regulation of heart contraction (GO:0008016) | 3.79852599 |
| 93 | * regulation of ATP catabolic process (GO:1903289) | 3.75490359 |
| 94 | * regulation of ATPase activity (GO:0043462) | 3.75490359 |
| 95 | glucan catabolic process (GO:0009251) | 3.66337419 |
| 96 | striated muscle atrophy (GO:0014891) | 3.62446507 |
| 97 | regulation of striated muscle cell apoptotic process (GO:0010662) | 3.61992104 |
| 98 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.60067103 |
| 99 | NADH metabolic process (GO:0006734) | 3.58436165 |
| 100 | cardiac conduction (GO:0061337) | 3.57426826 |
| 101 | response to inactivity (GO:0014854) | 3.57223361 |
| 102 | trabecula formation (GO:0060343) | 3.55972425 |
| 103 | * muscle contraction (GO:0006936) | 3.55298898 |
| 104 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.53582565 |
| 105 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.50493920 |
| 106 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.50493920 |
| 107 | positive regulation of myotube differentiation (GO:0010831) | 3.49773401 |
| 108 | cardiac chamber formation (GO:0003207) | 3.48669278 |
| 109 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.46240029 |
| 110 | muscle organ development (GO:0007517) | 3.46233840 |
| 111 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.46140619 |
| 112 | * regulation of muscle system process (GO:0090257) | 3.46070306 |
| 113 | regulation of myoblast differentiation (GO:0045661) | 3.45701039 |
| 114 | muscle structure development (GO:0061061) | 3.45034073 |
| 115 | cellular polysaccharide catabolic process (GO:0044247) | 3.43757399 |
| 116 | * regulation of muscle contraction (GO:0006937) | 3.42089936 |
| 117 | striated muscle adaptation (GO:0014888) | 3.40941478 |
| 118 | muscle cell development (GO:0055001) | 3.40845878 |
| 119 | * muscle system process (GO:0003012) | 3.36172626 |
| 120 | regulation of sulfur metabolic process (GO:0042762) | 3.34969993 |
| 121 | positive regulation of cation channel activity (GO:2001259) | 3.34340625 |
| 122 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.32712483 |
| 123 | carnitine transmembrane transport (GO:1902603) | 3.30857614 |
| 124 | positive regulation of heart rate (GO:0010460) | 3.30491141 |
| 125 | relaxation of muscle (GO:0090075) | 3.29459051 |
| 126 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.29117547 |
| 127 | cardiac ventricle formation (GO:0003211) | 3.28649454 |
| 128 | 2-oxoglutarate metabolic process (GO:0006103) | 3.26524502 |
| 129 | positive regulation of heart contraction (GO:0045823) | 3.26238593 |
| 130 | muscle atrophy (GO:0014889) | 3.22224572 |
| 131 | ATP biosynthetic process (GO:0006754) | 3.19749864 |
| 132 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.17118735 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.87558659 |
| 2 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 6.08138406 |
| 3 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 5.18161685 |
| 4 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 4.70588130 |
| 5 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 4.51073578 |
| 6 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 4.51073578 |
| 7 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 3.94914360 |
| 8 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.82564777 |
| 9 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.59145415 |
| 10 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 3.08612020 |
| 11 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.96510064 |
| 12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.85465563 |
| 13 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.70314105 |
| 14 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 2.65984310 |
| 15 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.61990481 |
| 16 | * CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.45289484 |
| 17 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 2.16898616 |
| 18 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.10914472 |
| 19 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.10801573 |
| 20 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.96183560 |
| 21 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.94237362 |
| 22 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.89213407 |
| 23 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.74161300 |
| 24 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.66987391 |
| 25 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.65016245 |
| 26 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.64254816 |
| 27 | GATA1_22025678_ChIP-Seq_K562_Human | 1.59916250 |
| 28 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.59675968 |
| 29 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.58240987 |
| 30 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.55574832 |
| 31 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.54534973 |
| 32 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.52208939 |
| 33 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.50804960 |
| 34 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.48629898 |
| 35 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.32715998 |
| 36 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.32258312 |
| 37 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.31904492 |
| 38 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.20491900 |
| 39 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.20440698 |
| 40 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.17492203 |
| 41 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.17163454 |
| 42 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.14311605 |
| 43 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.14054843 |
| 44 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.13680397 |
| 45 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.12308281 |
| 46 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.12064538 |
| 47 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.11501483 |
| 48 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.09415837 |
| 49 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.09176051 |
| 50 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.08180494 |
| 51 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.06788839 |
| 52 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.06106162 |
| 53 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.06073995 |
| 54 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.01995914 |
| 55 | GATA1_19941826_ChIP-Seq_K562_Human | 1.00940141 |
| 56 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.00503382 |
| 57 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.98552540 |
| 58 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.98349646 |
| 59 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.97069170 |
| 60 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.94569610 |
| 61 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.94505175 |
| 62 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.93632455 |
| 63 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.93614940 |
| 64 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.92866383 |
| 65 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.91549295 |
| 66 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.91231069 |
| 67 | CJUN_26792858_Chip-Seq_BT549_Human | 0.90545421 |
| 68 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.90276621 |
| 69 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.89487146 |
| 70 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.88781514 |
| 71 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.88489168 |
| 72 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.88186144 |
| 73 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.87623787 |
| 74 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.86721322 |
| 75 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.86577868 |
| 76 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.85967483 |
| 77 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.85967483 |
| 78 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.84900898 |
| 79 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.84619221 |
| 80 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.84172119 |
| 81 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.84161638 |
| 82 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.84107408 |
| 83 | ATF3_27146783_Chip-Seq_COLON_Human | 0.83697516 |
| 84 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.83431872 |
| 85 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.83179659 |
| 86 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.83084506 |
| 87 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.82969987 |
| 88 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.82582891 |
| 89 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.82552710 |
| 90 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.82227887 |
| 91 | * MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.81614359 |
| 92 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.80179056 |
| 93 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.80127756 |
| 94 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.79857862 |
| 95 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.79141842 |
| 96 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.79121152 |
| 97 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.79049493 |
| 98 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.78294023 |
| 99 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.78291256 |
| 100 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.77933052 |
| 101 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.77824021 |
| 102 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.77808597 |
| 103 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.77424683 |
| 104 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.77061296 |
| 105 | VDR_22108803_ChIP-Seq_LS180_Human | 0.76449950 |
| 106 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.76274037 |
| 107 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.76037592 |
| 108 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.75669141 |
| 109 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.75668702 |
| 110 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.75471700 |
| 111 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.73656085 |
| 112 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.73648641 |
| 113 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.73156083 |
| 114 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.73146348 |
| 115 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.72995959 |
| 116 | GATA2_19941826_ChIP-Seq_K562_Human | 0.72659204 |
| 117 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.72442510 |
| 118 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.72348305 |
| 119 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.72150113 |
| 120 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.71985581 |
| 121 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.71911119 |
| 122 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.71646658 |
| 123 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.71581259 |
| 124 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.71529982 |
| 125 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.70813128 |
| 126 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.69825378 |
| 127 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.69335659 |
| 128 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.69044035 |
| 129 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.68713888 |
| 130 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.67817981 |
| 131 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.67745341 |
| 132 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.67182829 |
| 133 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.67084509 |
| 134 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.64765188 |
| 135 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.62721678 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 6.58606043 |
| 2 | MP0004084_abnormal_cardiac_muscle | 6.34011634 |
| 3 | MP0003646_muscle_fatigue | 4.94623914 |
| 4 | MP0000751_myopathy | 4.92247224 |
| 5 | MP0004215_abnormal_myocardial_fiber | 4.81472819 |
| 6 | MP0004036_abnormal_muscle_relaxation | 4.50826348 |
| 7 | MP0000749_muscle_degeneration | 4.34145407 |
| 8 | MP0005330_cardiomyopathy | 4.09077349 |
| 9 | MP0002972_abnormal_cardiac_muscle | 3.44736378 |
| 10 | MP0004087_abnormal_muscle_fiber | 3.18808659 |
| 11 | MP0008775_abnormal_heart_ventricle | 3.17170591 |
| 12 | MP0003137_abnormal_impulse_conducting | 3.00039220 |
| 13 | MP0005620_abnormal_muscle_contractility | 2.81195814 |
| 14 | MP0010630_abnormal_cardiac_muscle | 2.79493998 |
| 15 | MP0005385_cardiovascular_system_phenoty | 2.74855063 |
| 16 | MP0001544_abnormal_cardiovascular_syste | 2.74855063 |
| 17 | MP0006138_congestive_heart_failure | 2.61738243 |
| 18 | MP0000750_abnormal_muscle_regeneration | 2.60520482 |
| 19 | MP0002106_abnormal_muscle_physiology | 2.54393405 |
| 20 | MP0003828_pulmonary_edema | 2.50467403 |
| 21 | MP0004484_altered_response_of | 2.46304351 |
| 22 | MP0004085_abnormal_heartbeat | 2.30855926 |
| 23 | MP0004145_abnormal_muscle_electrophysio | 2.30389433 |
| 24 | MP0002269_muscular_atrophy | 2.28769677 |
| 25 | MP0004510_myositis | 2.20164752 |
| 26 | MP0003221_abnormal_cardiomyocyte_apopto | 2.17645162 |
| 27 | MP0004130_abnormal_muscle_cell | 2.07329373 |
| 28 | MP0005369_muscle_phenotype | 2.04584924 |
| 29 | MP0002127_abnormal_cardiovascular_syste | 1.92665876 |
| 30 | MP0000759_abnormal_skeletal_muscle | 1.90992185 |
| 31 | MP0000747_muscle_weakness | 1.90669278 |
| 32 | MP0003950_abnormal_plasma_membrane | 1.87828182 |
| 33 | MP0006036_abnormal_mitochondrial_physio | 1.71488579 |
| 34 | MP0004233_abnormal_muscle_weight | 1.66861532 |
| 35 | MP0003567_abnormal_fetal_cardiomyocyte | 1.59975954 |
| 36 | MP0002332_abnormal_exercise_endurance | 1.30742182 |
| 37 | MP0000266_abnormal_heart_morphology | 1.22924343 |
| 38 | MP0003279_aneurysm | 1.19190115 |
| 39 | MP0010368_abnormal_lymphatic_system | 1.12154052 |
| 40 | MP0001661_extended_life_span | 1.12045365 |
| 41 | MP0005451_abnormal_body_composition | 1.11173407 |
| 42 | MP0000343_altered_response_to | 1.08534105 |
| 43 | MP0005666_abnormal_adipose_tissue | 1.07204283 |
| 44 | MP0002234_abnormal_pharynx_morphology | 1.05787097 |
| 45 | MP0004270_analgesia | 1.02166868 |
| 46 | MP0006035_abnormal_mitochondrial_morpho | 1.00658587 |
| 47 | MP0005670_abnormal_white_adipose | 0.99317536 |
| 48 | MP0005165_increased_susceptibility_to | 0.98506856 |
| 49 | MP0002128_abnormal_blood_circulation | 0.84328971 |
| 50 | MP0003566_abnormal_cell_adhesion | 0.84053590 |
| 51 | MP0000230_abnormal_systemic_arterial | 0.81918949 |
| 52 | MP0005266_abnormal_metabolism | 0.75765735 |
| 53 | MP0005623_abnormal_meninges_morphology | 0.74307269 |
| 54 | MP0004272_abnormal_basement_membrane | 0.74267802 |
| 55 | MP0002108_abnormal_muscle_morphology | 0.74208806 |
| 56 | MP0000767_abnormal_smooth_muscle | 0.73899041 |
| 57 | MP0003806_abnormal_nucleotide_metabolis | 0.67231698 |
| 58 | MP0005375_adipose_tissue_phenotype | 0.67171299 |
| 59 | MP0001879_abnormal_lymphatic_vessel | 0.63978461 |
| 60 | MP0000733_abnormal_muscle_development | 0.62535884 |
| 61 | MP0004185_abnormal_adipocyte_glucose | 0.59830075 |
| 62 | MP0003045_fibrosis | 0.59577748 |
| 63 | MP0009780_abnormal_chondrocyte_physiolo | 0.58742514 |
| 64 | MP0009384_cardiac_valve_regurgitation | 0.56305832 |
| 65 | MP0002925_abnormal_cardiovascular_devel | 0.55942097 |
| 66 | MP0003984_embryonic_growth_retardation | 0.55594171 |
| 67 | MP0002088_abnormal_embryonic_growth/wei | 0.55087065 |
| 68 | MP0001299_abnormal_eye_distance/ | 0.53589158 |
| 69 | MP0003705_abnormal_hypodermis_morpholog | 0.52556824 |
| 70 | MP0002822_catalepsy | 0.51855930 |
| 71 | MP0008438_abnormal_cutaneous_collagen | 0.48800007 |
| 72 | MP0003122_maternal_imprinting | 0.45601083 |
| 73 | MP0001784_abnormal_fluid_regulation | 0.44645034 |
| 74 | MP0001614_abnormal_blood_vessel | 0.42898627 |
| 75 | MP0002909_abnormal_adrenal_gland | 0.42521492 |
| 76 | MP0008569_lethality_at_weaning | 0.40821218 |
| 77 | MP0004043_abnormal_pH_regulation | 0.40019944 |
| 78 | MP0005187_abnormal_penis_morphology | 0.39876713 |
| 79 | MP0005319_abnormal_enzyme/_coenzyme | 0.39048366 |
| 80 | MP0002971_abnormal_brown_adipose | 0.38725548 |
| 81 | MP0003941_abnormal_skin_development | 0.37758427 |
| 82 | MP0003948_abnormal_gas_homeostasis | 0.35790756 |
| 83 | MP0000003_abnormal_adipose_tissue | 0.34505361 |
| 84 | MP0004147_increased_porphyrin_level | 0.34117052 |
| 85 | MP0000013_abnormal_adipose_tissue | 0.33560693 |
| 86 | MP0000372_irregular_coat_pigmentation | 0.33471391 |
| 87 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.33154670 |
| 88 | MP0010030_abnormal_orbit_morphology | 0.33141007 |
| 89 | MP0005595_abnormal_vascular_smooth | 0.33044206 |
| 90 | MP0001672_abnormal_embryogenesis/_devel | 0.32899427 |
| 91 | MP0005380_embryogenesis_phenotype | 0.32899427 |
| 92 | MP0002078_abnormal_glucose_homeostasis | 0.31519406 |
| 93 | MP0003879_abnormal_hair_cell | 0.29801603 |
| 94 | MP0004134_abnormal_chest_morphology | 0.28701494 |
| 95 | MP0002638_abnormal_pupillary_reflex | 0.28515906 |
| 96 | MP0005275_abnormal_skin_tensile | 0.28000667 |
| 97 | MP0002133_abnormal_respiratory_system | 0.26496281 |
| 98 | MP0005388_respiratory_system_phenotype | 0.26496281 |
| 99 | MP0005167_abnormal_blood-brain_barrier | 0.25995098 |
| 100 | MP0003656_abnormal_erythrocyte_physiolo | 0.25625055 |
| 101 | MP0001727_abnormal_embryo_implantation | 0.25205457 |
| 102 | MP0005377_hearing/vestibular/ear_phenot | 0.23915376 |
| 103 | MP0003878_abnormal_ear_physiology | 0.23915376 |
| 104 | MP0009250_abnormal_appendicular_skeleto | 0.23093372 |
| 105 | MP0005334_abnormal_fat_pad | 0.21405184 |
| 106 | MP0002114_abnormal_axial_skeleton | 0.20689769 |
| 107 | MP0005503_abnormal_tendon_morphology | 0.20440375 |
| 108 | MP0002896_abnormal_bone_mineralization | 0.20401055 |
| 109 | MP0005452_abnormal_adipose_tissue | 0.20165333 |
| 110 | MP0005386_behavior/neurological_phenoty | 0.19902747 |
| 111 | MP0004924_abnormal_behavior | 0.19902747 |
| 112 | MP0009672_abnormal_birth_weight | 0.19122760 |
| 113 | MP0000249_abnormal_blood_vessel | 0.18672550 |
| 114 | MP0005535_abnormal_body_temperature | 0.18634362 |
| 115 | MP0003385_abnormal_body_wall | 0.18610338 |
| 116 | MP0005332_abnormal_amino_acid | 0.18609065 |
| 117 | MP0004142_abnormal_muscle_tone | 0.18162276 |
| 118 | MP0005166_decreased_susceptibility_to | 0.17839276 |
| 119 | MP0008961_abnormal_basal_metabolism | 0.16652322 |
| 120 | MP0005376_homeostasis/metabolism_phenot | 0.15990984 |
| 121 | MP0001175_abnormal_lung_morphology | 0.14921030 |
| 122 | MP0002295_abnormal_pulmonary_circulatio | 0.14891312 |
| 123 | MP0003935_abnormal_craniofacial_develop | 0.13147615 |
| 124 | MP0000762_abnormal_tongue_morphology | 0.12338238 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 8.41700587 |
| 2 | Ventricular tachycardia (HP:0004756) | 7.07106407 |
| 3 | Calf muscle hypertrophy (HP:0008981) | 6.64399365 |
| 4 | Atrial fibrillation (HP:0005110) | 6.37965852 |
| 5 | Exercise-induced muscle cramps (HP:0003710) | 6.11227541 |
| 6 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.98812274 |
| 7 | Primary atrial arrhythmia (HP:0001692) | 5.95336244 |
| 8 | Supraventricular tachycardia (HP:0004755) | 5.76410479 |
| 9 | Exercise-induced myalgia (HP:0003738) | 5.70620983 |
| 10 | Supraventricular arrhythmia (HP:0005115) | 5.64554302 |
| 11 | Abnormality of the left ventricular outflow tract (HP:0011103) | 5.53695479 |
| 12 | Subaortic stenosis (HP:0001682) | 5.53695479 |
| 13 | Abnormality of the calf musculature (HP:0001430) | 5.52609287 |
| 14 | * Lipoatrophy (HP:0100578) | 5.43176112 |
| 15 | Muscle fiber splitting (HP:0003555) | 5.25988891 |
| 16 | Right ventricular cardiomyopathy (HP:0011663) | 4.96995295 |
| 17 | Hyporeflexia of lower limbs (HP:0002600) | 4.90365192 |
| 18 | Syncope (HP:0001279) | 4.88854021 |
| 19 | Distal arthrogryposis (HP:0005684) | 4.81270760 |
| 20 | Myopathic facies (HP:0002058) | 4.65388260 |
| 21 | Myoglobinuria (HP:0002913) | 4.57203073 |
| 22 | Prolonged QT interval (HP:0001657) | 4.47941975 |
| 23 | * Dilated cardiomyopathy (HP:0001644) | 4.44555009 |
| 24 | Palpitations (HP:0001962) | 4.43171345 |
| 25 | EMG: myopathic abnormalities (HP:0003458) | 4.35747346 |
| 26 | Bundle branch block (HP:0011710) | 4.24930517 |
| 27 | Ventricular arrhythmia (HP:0004308) | 4.24370910 |
| 28 | Round ear (HP:0100830) | 4.13750043 |
| 29 | Asymmetric septal hypertrophy (HP:0001670) | 4.06058016 |
| 30 | Ulnar deviation of the wrist (HP:0003049) | 3.76428732 |
| 31 | Heart block (HP:0012722) | 3.68753945 |
| 32 | Ventricular fibrillation (HP:0001663) | 3.62975575 |
| 33 | Rhabdomyolysis (HP:0003201) | 3.59704019 |
| 34 | Atrioventricular block (HP:0001678) | 3.56527263 |
| 35 | Abnormal atrioventricular conduction (HP:0005150) | 3.47914641 |
| 36 | Increased connective tissue (HP:0009025) | 3.46468995 |
| 37 | Acute necrotizing encephalopathy (HP:0006965) | 3.23566498 |
| 38 | Calcaneovalgus deformity (HP:0001848) | 3.23419649 |
| 39 | Abnormal EKG (HP:0003115) | 3.22297015 |
| 40 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.21598714 |
| 41 | Type 1 muscle fiber predominance (HP:0003803) | 3.16362490 |
| 42 | Left ventricular hypertrophy (HP:0001712) | 3.13280069 |
| 43 | Myotonia (HP:0002486) | 3.08355425 |
| 44 | Frequent falls (HP:0002359) | 3.07116299 |
| 45 | Hepatic necrosis (HP:0002605) | 3.04750628 |
| 46 | Difficulty running (HP:0009046) | 2.98234851 |
| 47 | Absent phalangeal crease (HP:0006109) | 2.96522795 |
| 48 | Deformed tarsal bones (HP:0008119) | 2.85254209 |
| 49 | Distal lower limb muscle weakness (HP:0009053) | 2.76072694 |
| 50 | Malignant hyperthermia (HP:0002047) | 2.74594405 |
| 51 | Ragged-red muscle fibers (HP:0003200) | 2.73224762 |
| 52 | Neck muscle weakness (HP:0000467) | 2.72322677 |
| 53 | Acute encephalopathy (HP:0006846) | 2.70009435 |
| 54 | Bulbar palsy (HP:0001283) | 2.67512655 |
| 55 | Progressive macrocephaly (HP:0004481) | 2.66582968 |
| 56 | Hepatocellular necrosis (HP:0001404) | 2.66359126 |
| 57 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.66017078 |
| 58 | * Palmoplantar keratoderma (HP:0000982) | 2.64854410 |
| 59 | Mitochondrial inheritance (HP:0001427) | 2.63552187 |
| 60 | Muscle fiber inclusion bodies (HP:0100299) | 2.62011550 |
| 61 | Difficulty climbing stairs (HP:0003551) | 2.60933785 |
| 62 | Weak cry (HP:0001612) | 2.54739774 |
| 63 | Conjunctival hamartoma (HP:0100780) | 2.52973305 |
| 64 | Increased CSF lactate (HP:0002490) | 2.51148575 |
| 65 | Hypoglycemic coma (HP:0001325) | 2.46310678 |
| 66 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.44440591 |
| 67 | Abnormal finger flexion creases (HP:0006143) | 2.43332710 |
| 68 | Double outlet right ventricle (HP:0001719) | 2.40928184 |
| 69 | Congenital malformation of the right heart (HP:0011723) | 2.40928184 |
| 70 | Ketoacidosis (HP:0001993) | 2.39682809 |
| 71 | Exercise intolerance (HP:0003546) | 2.38699424 |
| 72 | Fetal akinesia sequence (HP:0001989) | 2.38457276 |
| 73 | Cerebral edema (HP:0002181) | 2.37787948 |
| 74 | Abnormality of the neuromuscular junction (HP:0003398) | 2.36691911 |
| 75 | Fatigable weakness (HP:0003473) | 2.36691911 |
| 76 | Areflexia of lower limbs (HP:0002522) | 2.35240323 |
| 77 | Progressive muscle weakness (HP:0003323) | 2.34246138 |
| 78 | Lower limb amyotrophy (HP:0007210) | 2.27205590 |
| 79 | Increased variability in muscle fiber diameter (HP:0003557) | 2.26849775 |
| 80 | Generalized muscle weakness (HP:0003324) | 2.26284593 |
| 81 | Increased muscle lipid content (HP:0009058) | 2.25713379 |
| 82 | Pheochromocytoma (HP:0002666) | 2.25126533 |
| 83 | Hip contracture (HP:0003273) | 2.22815737 |
| 84 | Muscle stiffness (HP:0003552) | 2.22778484 |
| 85 | Abnormality of the foot musculature (HP:0001436) | 2.21883709 |
| 86 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.20925942 |
| 87 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.20560960 |
| 88 | Limb-girdle muscle atrophy (HP:0003797) | 2.16530641 |
| 89 | Neoplasm of the adrenal gland (HP:0100631) | 2.16328116 |
| 90 | Nemaline bodies (HP:0003798) | 2.16246418 |
| 91 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.15226920 |
| 92 | Dicarboxylic aciduria (HP:0003215) | 2.15226920 |
| 93 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.13003704 |
| 94 | EMG: neuropathic changes (HP:0003445) | 2.12796615 |
| 95 | Proximal amyotrophy (HP:0007126) | 2.11525456 |
| 96 | Rimmed vacuoles (HP:0003805) | 2.11442972 |
| 97 | Lactic acidosis (HP:0003128) | 2.10551427 |
| 98 | Respiratory failure (HP:0002878) | 2.09682600 |
| 99 | Sudden cardiac death (HP:0001645) | 2.09525143 |
| 100 | Congestive heart failure (HP:0001635) | 2.05922633 |
| 101 | Increased intramyocellular lipid droplets (HP:0012240) | 2.05186526 |
| 102 | Waddling gait (HP:0002515) | 2.05155833 |
| 103 | Neuroendocrine neoplasm (HP:0100634) | 2.04021170 |
| 104 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.02370543 |
| 105 | Gowers sign (HP:0003391) | 2.02048163 |
| 106 | Slender build (HP:0001533) | 2.01803573 |
| 107 | Popliteal pterygium (HP:0009756) | 2.01678518 |
| 108 | Hypoplastic left heart (HP:0004383) | 2.01247100 |
| 109 | Increased serum pyruvate (HP:0003542) | 2.00585095 |
| 110 | Abnormality of glycolysis (HP:0004366) | 2.00585095 |
| 111 | Testicular atrophy (HP:0000029) | 2.00190231 |
| 112 | Spinal rigidity (HP:0003306) | 1.99747408 |
| 113 | Hypoplastic heart (HP:0001961) | 1.99156295 |
| 114 | Foot dorsiflexor weakness (HP:0009027) | 1.97353335 |
| 115 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.97219789 |
| 116 | Hamartoma of the eye (HP:0010568) | 1.92056450 |
| 117 | Type 2 muscle fiber atrophy (HP:0003554) | 1.85555859 |
| 118 | Scapular winging (HP:0003691) | 1.82220139 |
| 119 | Abnormality of the calcaneus (HP:0008364) | 1.80884927 |
| 120 | Muscular dystrophy (HP:0003560) | 1.79476996 |
| 121 | Hyperkalemia (HP:0002153) | 1.79306409 |
| 122 | Distal lower limb amyotrophy (HP:0008944) | 1.77328094 |
| 123 | Diaphragmatic weakness (HP:0009113) | 1.77081619 |
| 124 | Lipid accumulation in hepatocytes (HP:0006561) | 1.75341262 |
| 125 | Esophageal neoplasm (HP:0100751) | 1.74351276 |
| 126 | Neoplasm of head and neck (HP:0012288) | 1.74351276 |
| 127 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.73549679 |
| 128 | Hyperalaninemia (HP:0003348) | 1.73549679 |
| 129 | Muscle fiber atrophy (HP:0100295) | 1.70862081 |
| 130 | Steppage gait (HP:0003376) | 1.69150985 |
| 131 | Aplasia of the musculature (HP:0100854) | 1.63051178 |
| 132 | Limb-girdle muscle weakness (HP:0003325) | 1.62749252 |
| 133 | Facial diplegia (HP:0001349) | 1.59910403 |
| 134 | Limited hip movement (HP:0008800) | 1.53077444 |
| 135 | Nonprogressive disorder (HP:0003680) | 1.51732974 |
| 136 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.48281241 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 6.30969558 |
| 2 | TTN | 5.15991006 |
| 3 | MYLK | 4.79685197 |
| 4 | LMTK2 | 3.50044752 |
| 5 | PKN2 | 3.37975807 |
| 6 | PHKG1 | 3.31805193 |
| 7 | PHKG2 | 3.31805193 |
| 8 | PDK4 | 3.07611637 |
| 9 | PDK3 | 3.07611637 |
| 10 | STK24 | 2.95734624 |
| 11 | DMPK | 2.95598424 |
| 12 | PIK3CA | 2.66232766 |
| 13 | MUSK | 2.53419617 |
| 14 | TRIB3 | 2.34017190 |
| 15 | NEK1 | 2.22533603 |
| 16 | BCKDK | 2.20631178 |
| 17 | TIE1 | 2.04661623 |
| 18 | ZAK | 1.91865133 |
| 19 | PDK2 | 1.80692230 |
| 20 | STK38L | 1.60221722 |
| 21 | PINK1 | 1.56322805 |
| 22 | ILK | 1.53045553 |
| 23 | CDC42BPA | 1.49259135 |
| 24 | PAK3 | 1.42658419 |
| 25 | GRK7 | 1.29555011 |
| 26 | CAMK2D | 1.24296687 |
| 27 | PRKD1 | 1.20871859 |
| 28 | MARK1 | 1.17920437 |
| 29 | ROCK1 | 1.14799898 |
| 30 | DAPK3 | 1.14215588 |
| 31 | STK4 | 1.13186770 |
| 32 | TRPM7 | 1.09557667 |
| 33 | FLT3 | 1.05247401 |
| 34 | WNK4 | 0.99390300 |
| 35 | MAP3K5 | 0.95744721 |
| 36 | MAPK12 | 0.94090269 |
| 37 | MOS | 0.91219560 |
| 38 | MAP3K7 | 0.86676682 |
| 39 | MAP2K4 | 0.81152621 |
| 40 | INSRR | 0.78759440 |
| 41 | PKN1 | 0.77112243 |
| 42 | EEF2K | 0.76269710 |
| 43 | PRKAA1 | 0.75289922 |
| 44 | CCNB1 | 0.72532093 |
| 45 | MAP2K3 | 0.71286277 |
| 46 | MAPKAPK3 | 0.71002753 |
| 47 | PRKAA2 | 0.69619055 |
| 48 | RIPK1 | 0.69348346 |
| 49 | PTK2B | 0.68657828 |
| 50 | CAMK4 | 0.66128181 |
| 51 | ROCK2 | 0.65154301 |
| 52 | MAP3K3 | 0.62880380 |
| 53 | CAMK2A | 0.62426576 |
| 54 | CAMK1 | 0.62176322 |
| 55 | MAPK4 | 0.58236118 |
| 56 | KDR | 0.57933088 |
| 57 | RPS6KL1 | 0.57429950 |
| 58 | RPS6KC1 | 0.57429950 |
| 59 | LIMK1 | 0.56298159 |
| 60 | PDGFRA | 0.56199407 |
| 61 | WNK1 | 0.55578077 |
| 62 | STK38 | 0.55253893 |
| 63 | DYRK1B | 0.55105847 |
| 64 | CAMK2B | 0.54446304 |
| 65 | MAP2K1 | 0.53859786 |
| 66 | MAP2K6 | 0.52628627 |
| 67 | PRKACB | 0.51529553 |
| 68 | RPS6KA6 | 0.48184442 |
| 69 | ERBB3 | 0.47362032 |
| 70 | KSR2 | 0.46194476 |
| 71 | MAP3K6 | 0.46160463 |
| 72 | TGFBR2 | 0.45254990 |
| 73 | STK39 | 0.44441136 |
| 74 | PRKCE | 0.43371637 |
| 75 | PRKD3 | 0.42622035 |
| 76 | PRKACA | 0.39917667 |
| 77 | AKT2 | 0.39176498 |
| 78 | MAP3K13 | 0.37404570 |
| 79 | EPHB2 | 0.35961907 |
| 80 | PIK3CG | 0.35729746 |
| 81 | NEK9 | 0.34434316 |
| 82 | EPHA3 | 0.33054268 |
| 83 | PRKACG | 0.32796404 |
| 84 | CAMK2G | 0.31727967 |
| 85 | PRKG2 | 0.29133132 |
| 86 | MAP3K10 | 0.28339577 |
| 87 | PRKG1 | 0.27113018 |
| 88 | ICK | 0.24250335 |
| 89 | PRKCH | 0.23283318 |
| 90 | SGK2 | 0.23083786 |
| 91 | MAPK10 | 0.22593852 |
| 92 | PDPK1 | 0.22133373 |
| 93 | NME2 | 0.22076081 |
| 94 | LATS2 | 0.21999515 |
| 95 | PDK1 | 0.19613144 |
| 96 | RPS6KB2 | 0.19546206 |
| 97 | PTK6 | 0.18962875 |
| 98 | RPS6KA1 | 0.18645480 |
| 99 | MARK2 | 0.18447324 |
| 100 | MARK3 | 0.18088328 |
| 101 | TBK1 | 0.18047608 |
| 102 | PRPF4B | 0.16959383 |
| 103 | EPHB1 | 0.16427480 |
| 104 | ARAF | 0.15693558 |
| 105 | ZAP70 | 0.15675337 |
| 106 | MAP3K1 | 0.14616721 |
| 107 | LATS1 | 0.13778392 |
| 108 | FER | 0.12645020 |
| 109 | TAOK2 | 0.12612619 |
| 110 | NME1 | 0.12114616 |
| 111 | MAPK7 | 0.11670917 |
| 112 | STK11 | 0.11316857 |
| 113 | PAK2 | 0.11133311 |
| 114 | RPS6KA3 | 0.10590546 |
| 115 | SGK3 | 0.10485622 |
| 116 | MAPKAPK2 | 0.10443120 |
| 117 | PRKCQ | 0.10338203 |
| 118 | RPS6KB1 | 0.09868855 |
| 119 | MTOR | 0.09310066 |
| 120 | FGFR1 | 0.09011886 |
| 121 | SGK1 | 0.08905565 |
| 122 | NLK | 0.08902196 |
| 123 | RAF1 | 0.08235435 |
| 124 | RPS6KA2 | 0.08091691 |
| 125 | LRRK2 | 0.06512301 |
| 126 | RET | 0.05704964 |
| 127 | UHMK1 | 0.04382049 |
| 128 | MAPK11 | 0.03976595 |
| 129 | STK3 | 0.03043984 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 6.02742926 |
| 2 | * Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.87591566 |
| 3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 4.16726043 |
| 4 | * Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.93765758 |
| 5 | * Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.89646491 |
| 6 | Parkinsons disease_Homo sapiens_hsa05012 | 3.73300296 |
| 7 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.63481585 |
| 8 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.97312631 |
| 9 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.90355588 |
| 10 | Alzheimers disease_Homo sapiens_hsa05010 | 2.69665873 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.57536320 |
| 12 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.54994267 |
| 13 | Carbon metabolism_Homo sapiens_hsa01200 | 2.54379896 |
| 14 | Huntingtons disease_Homo sapiens_hsa05016 | 2.41207130 |
| 15 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.40329712 |
| 16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.98025142 |
| 17 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.93894465 |
| 18 | * Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.83865355 |
| 19 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.75366409 |
| 20 | Viral myocarditis_Homo sapiens_hsa05416 | 1.69232123 |
| 21 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.51524473 |
| 22 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.43401093 |
| 23 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.27334659 |
| 24 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.22604281 |
| 25 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.15886128 |
| 26 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.11701522 |
| 27 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.09036302 |
| 28 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.99639124 |
| 29 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.95736710 |
| 30 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.92517162 |
| 31 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.89910764 |
| 32 | Insulin resistance_Homo sapiens_hsa04931 | 0.89490060 |
| 33 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.85953745 |
| 34 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.83232806 |
| 35 | Focal adhesion_Homo sapiens_hsa04510 | 0.77754022 |
| 36 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.75805261 |
| 37 | Tight junction_Homo sapiens_hsa04530 | 0.75638071 |
| 38 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.74581942 |
| 39 | Galactose metabolism_Homo sapiens_hsa00052 | 0.72905225 |
| 40 | Lysine degradation_Homo sapiens_hsa00310 | 0.65306768 |
| 41 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.64628141 |
| 42 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.64197626 |
| 43 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.63666413 |
| 44 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.63588549 |
| 45 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.63175398 |
| 46 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.62006562 |
| 47 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.58020895 |
| 48 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.57835742 |
| 49 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.57542619 |
| 50 | * Calcium signaling pathway_Homo sapiens_hsa04020 | 0.57520726 |
| 51 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.52412613 |
| 52 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.48966397 |
| 53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.48733906 |
| 54 | Long-term potentiation_Homo sapiens_hsa04720 | 0.48536639 |
| 55 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.47962198 |
| 56 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.46014469 |
| 57 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.45407152 |
| 58 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.45048696 |
| 59 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.43193684 |
| 60 | Adherens junction_Homo sapiens_hsa04520 | 0.41644820 |
| 61 | Peroxisome_Homo sapiens_hsa04146 | 0.37375863 |
| 62 | Salivary secretion_Homo sapiens_hsa04970 | 0.37206094 |
| 63 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.36075935 |
| 64 | Renin secretion_Homo sapiens_hsa04924 | 0.33112242 |
| 65 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.32237506 |
| 66 | Metabolic pathways_Homo sapiens_hsa01100 | 0.29548470 |
| 67 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.28872885 |
| 68 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.28837033 |
| 69 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.28228814 |
| 70 | Insulin secretion_Homo sapiens_hsa04911 | 0.27735475 |
| 71 | Bile secretion_Homo sapiens_hsa04976 | 0.26413820 |
| 72 | Amoebiasis_Homo sapiens_hsa05146 | 0.26040933 |
| 73 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.25752635 |
| 74 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.24020347 |
| 75 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.23684060 |
| 76 | Circadian entrainment_Homo sapiens_hsa04713 | 0.23161008 |
| 77 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.22604194 |
| 78 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.21804715 |
| 79 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.21353980 |
| 80 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.21333754 |
| 81 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.20813296 |
| 82 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.20606179 |
| 83 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.20070906 |
| 84 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.19468721 |
| 85 | Sulfur relay system_Homo sapiens_hsa04122 | 0.16222994 |
| 86 | Circadian rhythm_Homo sapiens_hsa04710 | 0.16000263 |
| 87 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.14254196 |
| 88 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.09389077 |
| 89 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.08804660 |
| 90 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.07203396 |
| 91 | Platelet activation_Homo sapiens_hsa04611 | 0.07107655 |
| 92 | Histidine metabolism_Homo sapiens_hsa00340 | 0.06547373 |
| 93 | Long-term depression_Homo sapiens_hsa04730 | 0.05849149 |
| 94 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.05583013 |
| 95 | Endometrial cancer_Homo sapiens_hsa05213 | 0.04513806 |
| 96 | Gap junction_Homo sapiens_hsa04540 | 0.03467354 |
| 97 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.01857955 |
| 98 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.01073212 |
| 99 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.01028127 |
| 100 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.00540622 |
| 101 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.00188195 |
| 102 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.00053266 |
| 103 | MAPK signaling pathway_Homo sapiens_hsa04010 | -0.0685914 |
| 104 | Toxoplasmosis_Homo sapiens_hsa05145 | -0.0422983 |
| 105 | VEGF signaling pathway_Homo sapiens_hsa04370 | -0.0413344 |
| 106 | Pancreatic secretion_Homo sapiens_hsa04972 | -0.0408163 |
| 107 | Notch signaling pathway_Homo sapiens_hsa04330 | -0.0372576 |
| 108 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | -0.0366640 |
| 109 | Olfactory transduction_Homo sapiens_hsa04740 | -0.0175552 |
| 110 | Taste transduction_Homo sapiens_hsa04742 | -0.0173929 |
| 111 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | -0.0092907 |
| 112 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | -0.0069192 |
| 113 | Melanogenesis_Homo sapiens_hsa04916 | -0.0034562 |
| 114 | Fat digestion and absorption_Homo sapiens_hsa04975 | -0.0026127 |
| 115 | FoxO signaling pathway_Homo sapiens_hsa04068 | -0.0002122 |

